Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

This pilot study aims to evaluate the feasibility and acceptability of nocturnal translational vestibular stimulations (VS) applied by a rocking bed (Somnomat Casa) for two months in patients with Parkinson's Disease.

Eligibility criteria

Qualifiers

Informed Consent signed by the subject

PD according to the MDS clinical diagnostic criteria for Parkinson's disease

Suffering from reduced sleep quality as defined by pathological cut-off (score of > 5) on the Pittsburgh Sleep Quality Index (PSQI)

Patients with stable antiparkinsonian, antidepressant, and sleep medications for six weeks before intervention and maintained on stable medication during the intervention period

Disqualifiers

Brain disease other than Parkinson's disease (e.g. atypical Parkinsonism, Alzheimer's disease, vascular dementia, multiple sclerosis, stroke, traumatic brain injury, epilepsy, etc.).

Dementia as defined by a MOCA score lower than 24/30

Weight > 150kg

Depression with acute suicidal ideation

Trial design

Treatments tested in this trial

  • Nocturnal translational vestibular stimulation

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators